NCT06303505

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: RECRUITING

Phase: PHASE1, PHASE2

Sponsor: Tubulis GmbH

Condition: Ovarian Cancer, Non-small Cell Lung Cancer

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: long_recruitment_duration_signal

Results signal: Low Signal

Operational burden: large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.